Form 8-K - Current report:
SEC Accession No. 0001683168-25-007265
Filing Date
2025-09-26
Accepted
2025-09-26 17:01:36
Documents
15
Period of Report
2025-09-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sonoma_8k.htm   iXBRL 8-K 32511
2 AT MARKET ISSUANCE SALES AGREEMENT sonoma_ex0101.htm EX-1.1 284800
3 OPINION OF POLSINELLI PC. sonoma_ex0501.htm EX-5.1 11252
4 GRAPHIC image_001.jpg GRAPHIC 4976
  Complete submission text file 0001683168-25-007265.txt   574852

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE snoa-20250926.xsd EX-101.SCH 3026
6 XBRL LABEL FILE snoa-20250926_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE snoa-20250926_pre.xml EX-101.PRE 22366
17 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3667
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 251351281
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)